Amneal Pharmaceuticals, Inc.

NasdaqGS:AMRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 2.99 B

Share Price

USD 9.53

Avg Daily Volume

1,623,027

Change (1 day)

1.27%

Change (1 year)

17.08%

Change (YTD)

20.33%

Amneal Pharmaceuticals, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 13.32%

Amneal Pharmaceuticals, Inc. Return on Equity (ROE) is 13.32% for the Trailing 12 Months (TTM) ending March 31, 2025, a -111.94% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Amneal Pharmaceuticals, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -111.52%, a 79.61% change year over year.
Amneal Pharmaceuticals, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was -62.09%, a 8,982.48% change year over year.
Amneal Pharmaceuticals, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was -0.68%, a -87.41% change year over year.
Amneal Pharmaceuticals, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was -5.43%, a -89.63% change year over year.